TMAO levels are significantly higher in the blood of individuals with cardiovascular, renal, neurological, and metabolic diseases
Patients may notice lower energy levels early in treatment due to reduced calorie intake
260 Conversely, TRAF6-mediated ubiquitination of HK2 facilitates its degradation via autophagy, reducing glycolytic activity
Exp Physiol 108:1227 Badenoch JB, Rengasamy ER, Watson C, Jansen K, Chakraborty S, Sundaram RD, Hafeez D, Burchill E, Saini A, Thomas L, Cross B, Hunt CK, Conti I, Ralovska S, Hussain Z, Butler M, Pollak TA, Koychev I, Michael BD, Holling H, Nicholson TR, Rogers JP, Rooney AG (2022) Persistent neuropsychiatric symptoms after Covid-19: a systematic review and meta-analysis